Open AccessStromal IL2 is related to the neutrophil/lymphocyte ratio in epithelial ovarian cancer
Author(s) -
Thiago de Santana Santos,
Millena Prata Jammal,
T. Silveira,
Eddie Fernando Cândido Murta,
Rosekeila Simões Nomelini
Publication year - 2019
Publication title -
pathologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.243
H-Index - 18
eISSN - 1591-951X
pISSN - 0031-2983
DOI - 10.32074/1591-951x-62-18
Subject(s) - medicine , neutrophil to lymphocyte ratio , ovarian cancer , lymphocyte , stromal cell , immunohistochemistry , cancer , oncology , immunology , pathology
There is a need for the development of new biomarkers for diagnosis and prognosis of ovarian cancer, which can ideally serve as targets for new therapeutic modalities and individualization of treatment. The objectives of this study were to determine the prognostic significance of the neutrophil/lymphocyte ratio in the peripheral blood of patients with ovarian cancer and tumor staging, and to associate this marker with the immune expression of a panel of cytokines.